Walleye Capital
OLMA icon

Walleye Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Walleye Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.2K Buy
+3,300
New +$73.5K ﹤0.01% 3905
2024
Q2 		– Sell
-2,500
Closed -$28.3K – 5878
2024
Q1 		$28.3K Sell
2,500
-11,600
-82% -$150K ﹤0.01% 4832
2023
Q4 		$198K Buy
14,100
+700
+5% +$9.41K ﹤0.01% 3685
2023
Q3 		$165K Buy
+13,400
New +$137K ﹤0.01% 3682

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Walleye Capital's OLMA Position: Q1 2026 in Review

Walleye Capital opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 21,247 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #3025 among its holdings. This is a return to the name: Walleye Capital previously reported a position in OLMA as recently as Q1 2025.

Walleye Capital first reported a position in OLMA in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.94M in Q3 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Walleye Capital held 21,247 shares of Olema Pharmaceuticals worth $317K as of Q1 2026.
  • Olema Pharmaceuticals was a new Walleye Capital position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3025 holding.
  • Walleye Capital first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 10 quarters since.
  • Walleye Capital's Olema Pharmaceuticals position peaked at $1.94M in Q3 2023.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.